Inside Information: Preliminary result of Martela Corporation’s directed share issue

Martela received subscriptions for 15,907,707 shares, about 89% of the offered shares, at EUR 0.45 each, for preliminary gross proceeds of approximately EUR 7.2 million. The company says proceeds will strengthen its financial position and liquidity and support development and efficiency measures; the offering could raise its share count to 20,698,119, with the new shares representing about 77% of post-issue shares. Final results are expected around October 6, with trading in the new shares estimated to begin October 13, 2026.

Analysis

The raise materially reduces near-term financing risk, but it is not yet evidence of a turnaround: proceeds are gross, and the release does not establish how much liquidity remains after transaction costs, debt service or ongoing cash burn. The key equity effect is a sharp reset in ownership economics: new shares are expected to represent roughly 77% of the post-transaction total, leaving existing holders with substantially less participation in any recovery. This may also create supply pressure when the new shares begin trading, although actual selling is unknown.

The 89% preliminary take-up is a constructive execution signal, not validation of the company’s stated efficiency plan or the adequacy of the capital raised. The contrarian risk is that investors may treat financing completion as a balance-sheet cure while overlooking whether recurring operations can fund themselves. No defensible valuation conclusion follows without the prevailing share price, debt maturities, post-raise cash and burn rate.

Near term, watch final allocation and registration/trading milestones for any change in issued shares or tradable supply. Over 1–3 months, the thesis turns on cash conversion, working-capital needs and measurable cost actions. Over 6–18 months, sustained operating cash generation—not the raise itself—would determine whether dilution bought durable stability.

Key Decisions for Investors

• For MARAS, avoid treating the completed financing as a standalone buy catalyst. Keep exposure cautious until final share count, net proceeds, cash balance and debt maturities clarify how much runway the raise actually provides.
• Expect potential near-term supply overhang as the new shares become tradable; do not assume the EUR 0.45 subscription price is a floor. Reassess after trading begins using actual turnover and price behavior rather than the preliminary take-up figure.
• Set a 1–3 month diligence trigger around operating cash flow, working-capital movements and evidence that efficiency actions are reducing costs. A continued cash drain or further financing need would falsify the liquidity-improvement thesis; sustained positive cash generation would strengthen it.
• No high-conviction directional trade is supported by this release alone. Verify post-issue liquidity, financing terms and current market valuation before sizing a position.